Havana, Cuba

Rosa Blanca Tormo Bravo

This inventor holds 1 USPTO granted patent. Top assignee: Centro De Inmunologia Molecular (Cim). Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rosa Blanca Tormo Bravo. Retrieved from https://idiyas.com/inventor/rosa-blanca-tormo-bravo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rosa Blanca Tormo Bravo: Innovator in Monoclonal Antibodies

Introduction

Rosa Blanca Tormo Bravo is a distinguished inventor based in Habana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. His innovative work has the potential to impact the treatment of various clinical conditions.

Latest Patents

Rosa holds a patent for "Anti-CD6 monoclonal antibodies and their uses." This patent involves monoclonal antibodies that specifically recognize the CD6 antigen. The pharmaceutical compositions derived from this invention are designed to achieve clinical and histological effectiveness in patients suffering from different types of psoriasis.

Career Highlights

Rosa is affiliated with the Centro de Inmunología Molecular, where he has been instrumental in advancing research in immunology. His work has garnered attention for its potential therapeutic applications, particularly in dermatological conditions.

Collaborations

Rosa has collaborated with notable colleagues, including Jose Enrique Montero Casimiro and Josefa Lombardero Valladares. These partnerships have contributed to the success of his research and the development of innovative treatments.

Conclusion

Rosa Blanca Tormo Bravo is a prominent figure in the field of immunology, with a focus on monoclonal antibodies. His contributions are paving the way for new therapeutic options for patients with psoriasis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…